9^9Be+120^{120}Sn scattering at near-barrier energies within a four body model

Cross sections for elastic and inelastic scattering of the weakly-bound $^9$Be nucleus on a $^{120}$Sn target have been measured at seven bombarding energies around and above the Coulomb barrier. The elastic angular distributions are analyzed with a four-body continuum-discretized coupled-channels (CDCC) calculation, which considers $^9$Be as a three-body projectile ($\alpha$ + $\alpha$ + n). An optical model analysis using the S\~ao Paulo potential is also shown for comparison. The CDCC analysis shows that the coupling to the continuum part of the spectrum is important for the agreement with experimental data even at energies around the Coulomb barrier, suggesting that breakup is an important process at low energies. At the highest incident energies, two inelastic peaks are observed at 1.19(5) and 2.41(5) MeV. Coupled-channels (CC) calculations using a rotational model confirm that the first inelastic peak corresponds to the excitation of the 2$_1^+$ state in $^{120}$Sn, while the second one likely corresponds to the excitation of the 3$_1^-$ state.Comment: 11 pages, 9 figures. Accepted as PR

Detecting Distributed Denial of Service Attacks in Neighbour Discovery Protocol Using Machine Learning Algorithm Based on Streams Representation

© 2018, Springer International Publishing AG, part of Springer Nature. The main protocol of the Internet protocol version 6 suites is the neighbour discovery protocol, which is geared towards substitution of address resolution protocol, router discovery, and function redirection in Internet protocol version 4. Internet protocol version 6 nodes employ neighbour discovery protocol to detect linked hosts and routers in Internet protocol version 6 network without the dependence on dynamic host configuration protocol server, which has earned the neighbour discovery protocol the title of the stateless protocol. The authentication process of the neighbour discovery protocol exhibits weaknesses that make this protocol vulnerable to attacks. Denial of service attacks can be triggered by a malicious host through the introduction of spoofed addresses in neighbour discovery protocol messages. Internet version 6 protocols are not well supported by Network Intrusion Detection System as is the case with Internet Protocol version 4 protocols. Several data mining techniques have been introduced to improve the classification mechanism of Intrusion detection system. In addition, extensive researches indicated that there is no Intrusion Detection system for Internet Protocol version 6 using advanced machine-learning techniques toward distributed denial of service attacks. This paper aims to detect Distributed Denial of Service attacks of the Neighbour Discovery protocol using machine-learning techniques, due to the severity of the attacks and the importance of Neighbour Discovery protocol in Internet Protocol version 6. Decision tree algorithm and Random Forest Algorithm showed high accuracy results in comparison to the other benchmarked algorithms

Interaction and Participation in Radio Plays: A Novel Approach to an Old Medium

Abstract. Radio plays have recently regained both popular interest and commercial success. Yet, listeners are not provided with either feedback channels or the ability to actively participate in this medium. The TAPE-Player concept described in the present paper extends the radio play medium by adding interactivity as well as participation to the production process. The user takes the roles of both actor and director, which includes verbal interpretation, recording, and editing the dialogues for the selected role(s) as the play’s script evolves. The creative freedom is supported by TAPE-Player’s underlying hypermedia architecture: audio clips are managed separately and combined dynamically to produce a personalised radio play. The applicability of the concept was corroborated in an empirical study. Specifically, the users welcomed the interaction via TAPE-Player’s easy-to-use interface, the creative freedom, and the substantial influence they had in producing radio plays in a personalised entertainment medium.

A randomized, controlled trial of 3.0 mg of liraglutide in weight management

BACKGROUND Obesity is a chronic disease with serious health consequences, but weight loss is difficult to maintain through lifestyle intervention alone. Liraglutide, a glucagonlike peptide-1 analogue, has been shown to have potential benefit for weight management at a once-daily dose of 3.0 mg, injected subcutaneously. METHODS We conducted a 56-week, double-blind trial involving 3731 patients who did not have type 2 diabetes and who had a body-mass index (BMI; the weight in kilograms divided by the square of the height in meters) of at least 30 or a BMI of at least 27 if they had treated or untreated dyslipidemia or hypertension. We randomly assigned patients in a 2:1 ratio to receive once-daily subcutaneous injections of liraglutide at a dose of 3.0 mg (2487 patients) or placebo (1244 patients); both groups received counseling on lifestyle modification. The coprimary end points were the change in body weight and the proportions of patients losing at least 5% and more than 10% of their initial body weight. RESULTS At baseline, the mean (±SD) age of the patients was 45.1±12.0 years, the mean weight was 106.2±21.4 kg, and the mean BMI was 38.3±6.4; a total of 78.5% of the patients were women and 61.2% had prediabetes. At week 56, patients in the liraglutide group had lost a mean of 8.4±7.3 kg of body weight, and those in the placebo group had lost a mean of 2.8±6.5 kg (a difference of -5.6 kg; 95% confidence interval, -6.0 to -5.1; P<0.001, with last-observation-carried-forward imputation). A total of 63.2% of the patients in the liraglutide group as compared with 27.1% in the placebo group lost at least 5% of their body weight (P<0.001), and 33.1% and 10.6%, respectively, lost more than 10% of their body weight (P<0.001). The most frequently reported adverse events with liraglutide were mild or moderate nausea and diarrhea. Serious events occurred in 6.2% of the patients in the liraglutide group and in 5.0% of the patients in the placebo group. CONCLUSIONS In this study, 3.0 mg of liraglutide, as an adjunct to diet and exercise, was associated with reduced body weight and improved metabolic control. (Funded by Novo Nordisk; SCALE Obesity and Prediabetes NN8022-1839 ClinicalTrials.gov number, NCT01272219.)